Literature DB >> 25920605

Meta-analysis of microRNA expression profiling studies in human cervical cancer.

Mei-Yi Li1, Xiao-Xia Hu.   

Abstract

Cervical cancer is one of the most common malignant tumors in women, and numerous studies have associated the disease with changes in microRNA (miRNA) expression. This meta-analysis aimed to consolidate and assess the results of these studies in order to identify potential miRNA biomarkers of cervical cancer. We systematically searched the literature for studies comparing miRNA expression between cervical cancer tissues and normal cervical tissues, and we meta-analyzed the result of 27 studies comprising 1,132 cancer samples and 943 normal samples. We used a vote-counting strategy that took into account total sample and mean fold-change, in order to comprehensively assess associations between certain miRNAs and cervical cancer occurrence and progression. The studies described 195 miRNAs that were significantly up-regulated and 96 microRNAs that were down-regulated in cervical cancer tissues (stage I-IV) relative to normal cervical tissues. Vote-counting analysis showed that up-regulation was most consistently reported for miR-20a and miR-21 (four studies), followed by miR-10a, miR-15b, miR-20b, miR-141, miR-200a, and miR-224 (three studies). Down-regulation was reported most consistently for miR-143 (seven studies), followed by miR-203 and miR-145 (six studies). Fourteen miRNA, respectively, showed a significantly correlated lymphatic node metastasis in eight studies. This meta-analysis has identified several miRNAs whose expression correlates reliably with cervical cancer. These should be probed in further studies to explore their potential as diagnostic biomarkers.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25920605     DOI: 10.1007/s12032-015-0510-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  56 in total

1.  miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cells.

Authors:  Jie Zhang; Fangxia Zheng; Gang Yu; Yanhua Yin; Qingyang Lu
Journal:  Biochem Biophys Res Commun       Date:  2013-10-10       Impact factor: 3.575

2.  Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm.

Authors:  Tak-hong Cheung; Kwun-nok Mimi Man; Mei-yung Yu; So-fan Yim; Nelson S S Siu; Keith W K Lo; Graeme Doran; Raymond R Y Wong; Vivian W Wang; David I Smith; Michael J Worley; Ross S Berkowitz; Tony K H Chung; Yick-fu Wong
Journal:  Cell Cycle       Date:  2012-08-01       Impact factor: 4.534

3.  MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.

Authors:  Mattia Boeri; Carla Verri; Davide Conte; Luca Roz; Piergiorgio Modena; Federica Facchinetti; Elisa Calabrò; Carlo M Croce; Ugo Pastorino; Gabriella Sozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

4.  Altered MicroRNA expression in cervical carcinomas.

Authors:  Jeong-Won Lee; Chel Hun Choi; Jung-Joo Choi; Young-Ae Park; Seung-Jun Kim; Seung Yong Hwang; Woo Young Kim; Tae-Joong Kim; Je-Ho Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

5.  MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.

Authors:  Min Luo; Dongxiang Shen; Xiaoning Zhou; Xiaodong Chen; Wei Wang
Journal:  Surgery       Date:  2013-02-28       Impact factor: 3.982

6.  Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells.

Authors:  Yukihiro Akao; Yoshihito Nakagawa; Akio Iio; Tomoki Naoe
Journal:  Leuk Res       Date:  2009-05-21       Impact factor: 3.156

7.  Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.

Authors:  Xiaohong Wang; Shuang Tang; Shu-Yun Le; Robert Lu; Janet S Rader; Craig Meyers; Zhi-Ming Zheng
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

8.  Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.

Authors:  Shu-na Shen; Ling-feng Wang; Yong-feng Jia; Yu-qing Hao; Lin Zhang; Hui Wang
Journal:  Diagn Pathol       Date:  2013-04-30       Impact factor: 2.644

9.  Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.

Authors:  Noriko Yamamoto; Takashi Kinoshita; Nijiro Nohata; Toshihiko Itesako; Hirofumi Yoshino; Hideki Enokida; Masayuki Nakagawa; Makio Shozu; Naohiko Seki
Journal:  Int J Oncol       Date:  2013-03-07       Impact factor: 5.650

10.  MicroRNA-92 regulates cervical tumorigenesis and its expression is upregulated by human papillomavirus-16 E6 in cervical cancer cells.

Authors:  Yu Yu; Yao Zhang; Shulan Zhang
Journal:  Oncol Lett       Date:  2013-06-17       Impact factor: 2.967

View more
  21 in total

1.  Pregnancy-associated changes in cervical noncoding RNA.

Authors:  Kristin D Gerson; Miriam J Haviland; Dayna Neo; Jonathan L Hecht; Andrea A Baccarelli; Kasey Jm Brennan; Alexandra E Dereix; Steven J Ralston; Michele R Hacker; Heather H Burris
Journal:  Epigenomics       Date:  2020-08-18       Impact factor: 4.778

Review 2.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

3.  miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer.

Authors:  Ju Guo; Zewen Xiao; Xingwei Yu; Runfu Cao
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

Review 4.  The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases-a literature review.

Authors:  Ester P Olthof; Maaike A van der Aa; Judit A Adam; Lukas J A Stalpers; Hans H B Wenzel; Jacobus van der Velden; Constantijne H Mom
Journal:  Int J Clin Oncol       Date:  2021-07-09       Impact factor: 3.402

5.  Identification of an 88-microRNA signature in whole blood for diagnosis of hepatocellular carcinoma and other chronic liver diseases.

Authors:  Xiao-Ran Long; Yao-Jun Zhang; Mei-Yin Zhang; Keng Chen; X F Steven Zheng; Hui-Yun Wang
Journal:  Aging (Albany NY)       Date:  2017-06-27       Impact factor: 5.682

6.  Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.

Authors:  Chunyu Li; Yunhong Yin; Xiao Liu; Xuejiao Xi; Weixiao Xue; Yiqing Qu
Journal:  Oncotarget       Date:  2017-04-11

Review 7.  Use of Mature miRNA Strand Selection in miRNAs Families in Cervical Cancer Development.

Authors:  Angelica Judith Granados-López; José Luis Ruiz-Carrillo; Luis Steven Servín-González; José Luis Martínez-Rodríguez; Claudia Araceli Reyes-Estrada; Rosalinda Gutiérrez-Hernández; Jesús Adrián López
Journal:  Int J Mol Sci       Date:  2017-02-14       Impact factor: 5.923

8.  Expression and Clinical Pathological Significance of miR-200a in Concurrent Cholangiocarcinoma Associated with Hepatolithiasis.

Authors:  Chen Chen; Dinghua Yang; Qunwei Wang; Xintian Wang
Journal:  Med Sci Monit       Date:  2015-11-20

9.  miR-224-3p inhibits autophagy in cervical cancer cells by targeting FIP200.

Authors:  Wang Fang; Shan Shu; Li Yongmei; Zhu Endong; Yin Lirong; Sun Bei
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

Review 10.  miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA).

Authors:  Bo Zheng; Seogsong Jeong; Yanjing Zhu; Lei Chen; Qiang Xia
Journal:  Oncotarget       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.